You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
Mallinckrodt
McKinsey
McKesson

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent Applications for CYMBALTA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for CYMBALTA

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial Arylpiperazines having activity at the serotonin 1A receptor 2001-01-03 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-04-19
  Start Trial   Start Trial ANTIDEPRESSANT EFFECT OF NOREPINEPHRINE UPTAKE 2 INHIBITORS AND COMBINED MEDICATIONS INCLUDING THEM 2001-03-16 Patented Case 2002-05-24
  Start Trial   Start Trial ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF 2002-03-06 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2015-07-13
  Start Trial   Start Trial AZABICYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-F]QUINOLINE AS 5-HT1A ANTAGONISTS 2002-04-24 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2013-04-01
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
Johnson and Johnson
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.